A detailed history of Freestone Capital Holdings, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 33,221 shares of NVO stock, worth $2.76 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
33,221
Previous 34,253 3.01%
Holding current value
$2.76 Million
Previous $4.89 Million 19.1%
% of portfolio
0.14%
Previous 0.18%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $122,880 - $150,073
-1,032 Reduced 3.01%
33,221 $3.96 Million
Q2 2024

Nov 22, 2024

SELL
$122.71 - $146.91 $11,412 - $13,662
-93 Reduced 0.27%
34,253 $4.89 Million
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $11,412 - $13,662
-93 Reduced 0.27%
34,253 $4.89 Million
Q1 2024

Nov 22, 2024

BUY
$102.11 - $135.92 $114,873 - $152,910
1,125 Added 3.39%
34,346 $4.41 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $63,308 - $84,270
-620 Reduced 1.77%
34,346 $4.41 Million
Q4 2023

Feb 13, 2024

SELL
$87.78 - $105.45 $15,098 - $18,137
-172 Reduced 0.49%
34,966 $3.62 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $1.55 Million - $3.39 Million
17,002 Added 93.75%
35,138 $3.2 Million
Q2 2023

Aug 09, 2023

SELL
$155.98 - $172.65 $246,448 - $272,787
-1,580 Reduced 8.01%
18,136 $2.93 Million
Q1 2023

May 12, 2023

SELL
$132.34 - $159.14 $101,901 - $122,537
-770 Reduced 3.76%
19,716 $3.14 Million
Q4 2022

Feb 13, 2023

SELL
$102.55 - $135.33 $1.12 Million - $1.48 Million
-10,910 Reduced 34.75%
20,486 $2.77 Million
Q3 2022

Nov 09, 2022

SELL
$95.28 - $116.93 $1.06 Million - $1.3 Million
-11,108 Reduced 26.13%
31,396 $3.13 Million
Q2 2022

Aug 09, 2022

SELL
$103.24 - $121.81 $852,865 - $1.01 Million
-8,261 Reduced 16.27%
42,504 $4.74 Million
Q1 2022

May 12, 2022

SELL
$93.1 - $112.54 $143,001 - $172,861
-1,536 Reduced 2.94%
50,765 $5.64 Million
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $261,848 - $319,745
-2,731 Reduced 4.96%
52,301 $5.86 Million
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $112,194 - $141,697
-1,329 Reduced 2.36%
55,032 $5.28 Million
Q2 2021

Aug 16, 2021

SELL
$67.66 - $84.76 $3,518 - $4,407
-52 Reduced 0.09%
56,361 $4.72 Million
Q1 2021

May 17, 2021

SELL
$67.06 - $75.82 $285,876 - $323,220
-4,263 Reduced 7.03%
56,413 $3.8 Million
Q4 2020

Feb 16, 2021

BUY
$63.89 - $73.8 $818,686 - $945,673
12,814 Added 26.77%
60,676 $4.24 Billion
Q3 2020

Nov 06, 2020

SELL
$63.69 - $70.22 $186,420 - $205,533
-2,927 Reduced 5.76%
47,862 $3.32 Million
Q2 2020

Aug 04, 2020

SELL
$58.54 - $67.94 $350,420 - $406,688
-5,986 Reduced 10.54%
50,789 $3.33 Million
Q1 2020

May 12, 2020

SELL
$49.46 - $64.78 $2.42 Million - $3.17 Million
-48,911 Reduced 46.28%
56,775 $3.42 Million
Q4 2019

Feb 04, 2020

SELL
$49.86 - $58.26 $1.85 Million - $2.17 Million
-37,187 Reduced 26.03%
105,686 $6.12 Million
Q3 2019

Nov 07, 2019

SELL
$47.54 - $53.43 $2.08 Million - $2.34 Million
-43,781 Reduced 23.46%
142,873 $7.39 Million
Q2 2019

Aug 05, 2019

SELL
$46.79 - $52.47 $1.14 Million - $1.28 Million
-24,464 Reduced 11.59%
186,654 $9.53 Million
Q1 2019

May 08, 2019

SELL
$46.36 - $52.63 $463,739 - $526,457
-10,003 Reduced 4.52%
211,118 $11 Million
Q4 2018

Feb 12, 2019

BUY
$41.54 - $47.25 $32,276 - $36,713
777 Added 0.35%
221,121 $10.2 Million
Q3 2018

Nov 13, 2018

SELL
$46.76 - $51.24 $373,331 - $409,100
-7,984 Reduced 3.5%
220,344 $10.4 Million
Q2 2018

Aug 14, 2018

BUY
$44.29 - $50.42 $261,355 - $297,528
5,901 Added 2.65%
228,328 $10.5 Million
Q1 2018

May 15, 2018

BUY
$48.49 - $58.14 $472,438 - $566,458
9,743 Added 4.58%
222,427 $11 Million
Q4 2017

Feb 13, 2018

BUY
$47.53 - $53.73 $377,625 - $426,884
7,945 Added 3.88%
212,684 $11.4 Million
Q3 2017

Nov 14, 2017

BUY
$41.15 - $49.22 $672,102 - $803,910
16,333 Added 8.67%
204,739 $9.86 Million
Q2 2017

Aug 15, 2017

BUY
N/A
188,406
188,406 $8.08 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $188B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Freestone Capital Holdings, LLC Portfolio

Follow Freestone Capital Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.